XPEL, Inc. (NASDAQ: XPEL) a global supplier of protecting movies and coatings nowadays announced that they have been picked as the distinctive supplier to Rivian Automotive LLC for their new paint protection movie (“PPF&CloseCurlyDoubleQuote) factory immediate program.

By the phrases of the arrangement, Rivian Automotive will provide manufacturing unit immediate PPF choices to its clients purchasing their new R1T and R1S models starting late 2022. Buyers will be capable to pick in between two PPF selection packages: Entrance Gloss Paint Guard or Total Entire body Satin Paint Guard. The Paint Guard offers have been designed cooperatively in between XPEL and Rivian&CloseCurlyQuotes motor vehicle engineering and layout groups to boost the adventures of R1T and R1S proprietors. XPEL will work an set up facility in near proximity to Rivian&CloseCurlyQuotes Regular, Illinois assembly plant, to be certain installation quality regulate.

“We&CloseCurlyQuotere pleased to have this prospect to convey our proprietary design and style methodology and state-of-the-art paint protection movies to Rivian clients as the exceptional provider of manufacturing unit direct PPF for their R1T and R1S motor vehicles,&CloseCurlyDoubleQuote commented Tim Hartt, Vice President – Technical Functions & OEM of XPEL. “We are the leader in sophisticated OEM amount PPF options and we look ahead to leveraging our practical experience as a tier 1 provider performing with high quality automotive manufacturers, to introduce XPEL goods to Rivian and their clients.&CloseCurlyDoubleQuote

ABOUT XPEL

XPEL is a leading provider of protective films and coatings, which include automotive paint safety movie, floor security movie, automotive and commercial/household window movies, and ceramic coatings. With a world wide footprint, a community of qualified installers and proprietary DAP program, XPEL is committed to exceeding shopper anticipations by providing superior-good quality goods, top buyer support, expert complex assistance and earth-course coaching. XPEL, Inc. is publicly traded on Nasdaq beneath the image “XPEL&CloseCurlyDoubleQuote.

www.xpel.com

Safe and sound harbor assertion

This launch incorporates forward-on the lookout statements about XPEL, Inc. and its small business, which could contain, but is not limited to, predicted use of proceeds from cash transactions, growth into new markets, and execution of the firm’s development system. Generally, but not usually, ahead-wanting statements can be recognized by the use of words and phrases such as “ideas,” “is expected,” “expects,” “scheduled,” “intends,” “contemplates,” “anticipates,” “believes,” “proposes” or versions (which include damaging variants) of these terms and phrases, or condition that sure steps, functions or effects “may possibly,” “could,” “would,” “might” or “will” be taken, happen or be attained. These statements are based on the present-day anticipations of the administration of XPEL. The forward-looking gatherings and circumstances talked about in this release could not take place by certain specified dates or at all and could vary materially as a end result of identified and unidentified possibility things and uncertainties influencing the organization, overall performance and acceptance of the firm’s products and solutions, economic components, competitors, the equity marketplaces generally and a lot of other things beyond the management of XPEL. Even though XPEL has tried to identify important factors that could bring about real actions, situations or benefits to differ materially from those people described in ahead-looking statements, there may possibly be other factors that trigger actions, events or benefits to vary from people anticipated, believed or intended. No ahead-searching assertion can be guaranteed. Besides as essential by relevant securities laws, ahead-wanting statements talk only as of the day on which they are designed and XPEL undertakes no obligation to publicly update or revise any forward-hunting statement, whether as a consequence of new data, upcoming events, or in any other case.